After beefing up the target of its global cost-savings drive once again, Pfizer is continuing to see its plan through with ...
Abbott has put the ball back in Serena Williams’ court to serve up a high-profile endorsement of the Lingo over-the-counter ...
After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the ...
After winning an approval decades in the making last year—and shuffling its executive roster throughout 2025—Geron ...
European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework ...
About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma ...
The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...
The new Lilly facilities—which include a $5 billion API plant near Richmond, Virginia, which was announced in September—are ...
With a new edition of a long-running awareness campaign, Genentech is drawing attention to the talents and passions that are ...
Biosecure Act slips into key US defense bill, teeing up potential China biopharma constraints in '26
While the China-targeting Biosecure Act failed to pass muster in a key defense spending bill last year, a retooled version of ...
Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...
Australia's CSL, which earlier this year paused plans to put its CSL Seqirus vaccine division up for sale, has opened the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback